Jennifer E. Cook, Director at Denali Therapeutics, holds 6.89K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 15.53K shares in Denali Therapeutics (Ticker: DNLI), holds 7.15K shares in BridgeBio Pharma (Ticker: BBIO). Most recently, Jennifer E. Cook Sold ― shares of Jazz Pharmaceuticals on Dec 06, 2023 for an estimated value of 49.74K.